These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2025576)

  • 1. Are 'dysplastic' and hypogranular megakaryocytes specific markers for myelodysplastic syndrome?
    Wong KF; Chan JK
    Br J Haematol; 1991 Apr; 77(4):509-14. PubMed ID: 2025576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of myelodysplastic syndromes and normal bone marrow biopsies with conventional staining and immunocytochemistry.
    Das R; Hayer J; Dey P; Garewal G
    Anal Quant Cytol Histol; 2005 Jun; 27(3):152-6. PubMed ID: 16121636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome analyses in patients with myelodysplastic syndromes: correlation with bone marrow histopathology and prognostic significance.
    Werner M; Maschek H; Kaloutsi V; Choritz H; Georgii A
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(1):47-52. PubMed ID: 1636249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed myelodysplastic and myeloproliferative syndromes.
    Neuwirtová R; Mociková K; Musilová J; Jelínek J; Havlícek F; Michalová K; Adamkov M
    Leuk Res; 1996 Sep; 20(9):717-26. PubMed ID: 8947580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trisomy 14 in myelodysplastic syndromes: report of two cases and review of the literature.
    Vasef MA; Murata-Collins JL; Alsabeh R; Medeiros LJ
    Arch Pathol Lab Med; 1998 Jan; 122(1):77-83. PubMed ID: 9448022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Megakaryocyte colony formation by bone marrow progenitors in myelodysplastic syndromes.
    Juvonen E; Partanen S; Knuutila S; Ruutu T
    Br J Haematol; 1986 Jun; 63(2):331-4. PubMed ID: 3718873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of the myelodysplastic syndromes.
    Bennett JM
    Clin Haematol; 1986 Nov; 15(4):909-23. PubMed ID: 3471370
    [No Abstract]   [Full Text] [Related]  

  • 8. Magnetic resonance imaging in myelodysplastic syndromes.
    Lewis S; Wainscoat JS; Moore NR; Golding SJ
    Br J Radiol; 1995 Feb; 68(806):121-7. PubMed ID: 7735740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated cellular senescence in myelodysplastic syndrome.
    Wang YY; Cen JN; He J; Shen HJ; Liu DD; Yao L; Qi XF; Chen ZX
    Exp Hematol; 2009 Nov; 37(11):1310-7. PubMed ID: 19748549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Megakaryocytic alterations in thrombocytopenia: a bone marrow aspiration study.
    Muhury M; Mathai AM; Rai S; Naik R; Pai MR; Sinha R
    Indian J Pathol Microbiol; 2009; 52(4):490-4. PubMed ID: 19805953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34/QBEND10 immunostaining in bone marrow biopsies: an additional parameter for the diagnosis and classification of myelodysplastic syndromes.
    Baur AS; Meugé-Moraw C; Schmidt PM; Parlier V; Jotterand M; Delacrétaz F
    Eur J Haematol; 2000 Feb; 64(2):71-9. PubMed ID: 10997326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual specific cutaneous lesions in myelodysplastic syndromes.
    Aractingi S; Bachmeyer C; Miclea JM; Vérola O; Rousselot P; Dubertret L; Daniel MT
    J Am Acad Dermatol; 1995 Aug; 33(2 Pt 1):187-91. PubMed ID: 7622643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Megakaryocytic ploidy in myelodysplastic syndromes.
    Kobayashi Y; Ozawa M; Maruo N; Kondo M
    Leuk Lymphoma; 1993 Jan; 9(1-2):55-61. PubMed ID: 8477202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atypical infiltration of megakaryocytes into the liver and spleen in a case of refractory anemia].
    Sato K; Ushijima T; Ohbayashi Y; Sato H; Urabe A
    Rinsho Ketsueki; 1990 Jul; 31(7):1004-7. PubMed ID: 2214179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colony formation by megakaryocyte progenitors in myelodysplatic syndromes.
    Juvonen E; Partanen S; Knuutila S; Ruutu T
    Eur J Haematol; 1989 Apr; 42(4):389-95. PubMed ID: 2721661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
    Hall J; Foucar K
    Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia.
    Huh YO; Jilani I; Estey E; Giles F; Kantarjian H; Freireich E; Albitar M
    Leukemia; 2002 Nov; 16(11):2249-52. PubMed ID: 12399969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of megakaryocytic morphology in diagnosing 5q- syndrome.
    Thiede T; Engquist L; Billström R
    Eur J Haematol; 1988 Nov; 41(5):434-7. PubMed ID: 3208866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The myelodysplastic syndromes. Part I. What are they? Part II. Classification.
    Galton DA
    Scand J Haematol Suppl; 1986; 45():11-20. PubMed ID: 3515515
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative study on bone marrow megakaryocytes in children with thrombocytopenic purpura, aplastic anemia and myelodysplastic syndrome].
    Hu T; Shi XD; Feng YL; Liu R; Li JH; Chen J; Wang TY
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):183-7. PubMed ID: 15833188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.